BioGaia AB (publ) (OTCMKTS:BIOGY – Get Free Report) shares were up 19.4% during mid-day trading on Thursday . The company traded as high as $12.36 and last traded at $12.36. Approximately 100 shares were traded during trading, a decline of 97% from the average daily volume of 3,712 shares. The stock had previously closed at $10.35.
BioGaia AB (publ) Stock Performance
The firm’s 50 day simple moving average is $11.03 and its 200 day simple moving average is $11.01.
BioGaia AB (publ) Company Profile
BioGaia AB (publ) is a Sweden-based biotechnology company specializing in the development, manufacturing and marketing of probiotic products for human and animal health. The company’s core research centers on select Lactobacillus reuteri strains, supported by extensive clinical studies to promote digestive wellness, immune support and oral health. BioGaia collaborates with academic institutions and healthcare organizations to translate scientific findings into consumer and medical applications.
BioGaia’s product portfolio includes probiotic drops, chewable tablets and oral health lozenges designed for infants, children and adults.
Further Reading
- Five stocks we like better than BioGaia AB (publ)
- Microsoft Just Flipped the AI Spending Narrative Overnight
- Qualcomm’s Turnaround Is Working, So Why Is Wall Street Selling?
- Meta’s Earnings Show Why Wall Street Is Losing Patience With AI Spending
- Can Starbucks Keep This Turnaround Going? The Latest Results Say Yes
Receive News & Ratings for BioGaia AB (publ) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioGaia AB (publ) and related companies with MarketBeat.com's FREE daily email newsletter.
